iSOFT Group Limited (ASX:ISF) Reaffirms FY10 Guidance and Says NPfIT Commitments on Track
iSOFT Group Limited (ASX:ISF) Reaffirms FY10 Guidance and Says NPfIT Commitments on Track

Sydney, Mar 15, 2010 AEST (ABN Newswire) - iSOFT Group Limited (googlechartASX:ISF), Australia's largest listed health information technology company, today reaffirmed its guidance for fiscal 2010 and said it is on track to achieve the agreed date for the rollout of Lorenzo at University Hospitals of Morecambe Bay NHS Trust under the UK's National Programme for IT (NPfIT).

Morecambe Bay "go-live"

iSOFT remains on track for the "go-live" of Lorenzo Regional Healthcare Release 1.9 at Morecambe Bay in accordance with the agreed schedule, contrary to recent speculation in media reports. iSOFT expects the milestone at Morecambe Bay to be met according to the timetable agreed between its partner Computer Sciences Corporation (CSC) and the NHS, and expects this achievement to trigger a cash payment to the company.

Revised agreement with CSC

The company is currently negotiating a revised agreement with CSC that is expected to underpin the second half of fiscal 2010 and lead to benefits in 2011 and beyond. The revised agreement, which is on track to be concluded in the coming weeks, will reshape the way iSOFT and CSC jointly market iSOFT and CSC-related solutions in England to build a stronger market presence for Lorenzo. Further details will be released when available.

Reaffirmed FY10 guidance

In view of the combination of the expected revised agreement with CSC and the growth in iSOFT's pipeline during the first quarter of fiscal 2010, the company expects full-year revenue growth, in local currency terms, towards the upper end of its guidance of between 6 - 10 percent.

Pound/euro currency movements

Since the company's guidance in mid-February this year, the Australian dollar has gained about 6% against the pound and the euro. As about 85% of the company's revenues are denominated in pounds and euros, the translation effect, if continued, will negatively impact EBITDA by A$5 million at the end of the second half versus the guidance provided in February.

Contact

Gary Cohen
Executive Chairman & CEO
iSOFT Group Limited
Tel: +61-2-8251-6700
Email: gary.cohen@isofthealth.com

Stuart Kelly
Director, Corporate Affairs
iSOFT Group Limited
Tel: +61-2-8251-6769
Mob: +61-404-082-361
Email: stuart.kelly@isofthealth.com


ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 2) (Last 30 Days: 21) (Since Published: 3274)